199730 Stock Chart & Stats
₩1569.00
-₩301.00(-16.10%)
―
--
Day’s Range― - ―
52-Week Range₩1,500.00 - ₩6,330.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)28.03K
Market Cap
₩7.63B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.45
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,864,367
10 Day Avg. Volume50,051
30 Day Avg. Volume28,026
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,395,007.34
Revenue Forecast (FY)₩80.91T
199730 FAQ
What was BioInfra Co.,Ltd.’s price range in the past 12 months?
BioInfra Co.,Ltd. lowest stock price was ₩1500.00 and its highest was ₩6330.00 in the past 12 months.
What is BioInfra Co.,Ltd.’s market cap?
BioInfra Co.,Ltd.’s market cap is ₩7.63B.
When is BioInfra Co.,Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioInfra Co.,Ltd.’s earnings last quarter?
Currently, no data Available
Is BioInfra Co.,Ltd. overvalued?
According to Wall Street analysts BioInfra Co.,Ltd.’s price is currently Undervalued.
Does BioInfra Co.,Ltd. pay dividends?
BioInfra Co.,Ltd. does not currently pay dividends.
What is BioInfra Co.,Ltd.’s EPS estimate?
BioInfra Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioInfra Co.,Ltd. have?
BioInfra Co.,Ltd. has 4,864,367 shares outstanding.
What happened to BioInfra Co.,Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioInfra Co.,Ltd.?
Currently, no hedge funds are holding shares in KR:199730
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SD Biotechnologies Co., Ltd.
―
OliPass Corp.
―
INNOGENE Co., Ltd.
―
From Bio Co., Ltd.
―
UDMTEK Co., Ltd.
―